ANDAORALTABLET
Approved
Jun 2020
Lifecycle
Post-LOE
Competitive Pressure
30/100
Clinical Trials
20
Mechanism of Action
Xanthine Oxidase Inhibitors
Pharmacologic Class:
Xanthine Oxidase Inhibitor
Clinical Trials (5)
A Study to Evaluate Efficacy of Dotinurad and Febuxostat for the Treatment of Participants With Gout
Started Dec 2021
451 enrolled
Gout
Drug Use Study of Febuxostat After Recent Changes in the Prescribing Information
Started Aug 2020
24,046 enrolled
GoutCardiovascular Diseases
A Study to Assess the Effect of Intensive Uric Acid (UA) Lowering Therapy With RDEA3170, Febuxostat, Dapagliflozin on Urinary Excretion of UA
Started Oct 2017
36 enrolled
Asymptomatic Hyperuricemia
Intensive Uric Acid Lowering With Verinurad and Febuxostat in Patients With Albuminuria
Started May 2017
60 enrolled
HyperuricemiaAlbuminuriaType 2 Diabetes
Phase 1, Febuxostat XR Relative Bioavailability Study
Started Aug 2015
78 enrolled
Healthy Volunteers